Publications by authors named "Akif Dogan"

Claim this Profile
M
Management of hepatotoxicity associated with CDK4/6 inhibitors and rechallenge strategies in metastatic hormone-positive, HER2-NEGATIVE BREAST CANCER.
Nurullah İlhan, Süleyman Baş, Onur Alkan, Akif Doğan, Nargiz Majidova

J Cancer Res Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis.
Sedat Yıldırım, Tugba Başoğlu, Akif Doğan, Goncagul Akdağ, Oguzcan Kınıkoğlu

BMC Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor-infiltrating lymphocytes as predictive biomarkers in neoadjuvant treatment of HER2-positive breast cancer.
Oğuzcan Kınıkoğlu, Yunus Emre Altıntaş, Anıl Yıldız, Goncagül Akdağ, Hamit Bal

Oncologist· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Inflammatory Differences Between Upper and Mid-Lower Rectal Cancers in Non-Metastatic Stage II-II Disease.
Fırat Mülküt, Cem Batuhan Ofluoğlu, Mustafa Kağan Başdoğan, İsa Caner Aydın, Akif Doğan

Curr Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regional and Gender-Based Distribution of KRAS Mutations in Metastatic Colorectal Cancer Patients in Turkey: An Observational Study.
Nurullah Ilhan, Faysal Dane, Erdem Goker, Kazım Uygun, Bülent Orhan

Medicina (Kaunas)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Incidence and Clinical Characteristics of Interstitial Lung Disease Associated with CDK4/6 Inhibitors in Breast Cancer Patients: A Retrospective Multicenter Study.
Nurullah İlhan, Akif Doğan, Hande Nur Erölmez, Fatih Atalah, Süleyman Baş

Medicina (Kaunas)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Effectiveness of Cyclin-Dependent Kinase 4/6 Inhibitors in Early- and Very Early-Onset Metastatic Breast Cancer: A Multicenter Study.
Akif Doğan, Nurullah İlhan, Goncagül Akdağ, Sedat Yıldırım, Mustafa Seyyar

Medicina (Kaunas)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A safe and effective treatment for refractory malignant ascites: the use of pigtail catheters.
Akif Doğan, Ömer Aydıner

Pol J Radiol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status.
Goncagul Akdag, Sedat Yildirim, Akif Dogan, Zeynep Yuksel Yasar, Hamit Bal

Chemotherapy· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Nargiz Majidova, Murat Sarı, Fatma Akdag Kahvecioglu, Erkan Ozcan, Mutıianur Ozkorkmaz Akdag, Akif Dogan

Oncol Res Treat· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Adjuvant Chemotherapy Benefit Patients with T4 N0 Colon Cancer?
Goncagul Akdag, Deniz Isik, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu

Medicina (Kaunas)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Prognostic Indicator for Immunotherapy Response: Lymphocyte-to-Albumin (LA) Ratio Predicts Survival in Metastatic NSCLC Patients.
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Eyyup Cavdar, Oguzcan Kinikoglu

Cancers (Basel)· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the Clinical Impact of RANK Pathway Inhibition in Advanced Breast Cancer: Insights From a Retrospective Study on CDK4/6 Inhibitors and Antiresorptive Therapy.
Goncagul Akdag, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu, Muhammed Edib Mokresh

Cureus· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy.
Sedat Yildirim, Akif Dogan, Goncagul Akdag, Zeynep Yüksel Yasar, Hamit Bal

Sci Rep· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic scores in pulmonary large cell neuroendocrine carcinoma: A retrospective cohort study.
Goncagul Akdag, Özkan Alan, Akif Dogan, Sedat Yildirim, Oguzcan Kinikoglu

Heliyon· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of surveillance versus adjuvant treatment for patients with stage-I seminoma: a single-center experience.
Goncagul Akdag, Ozkan Alan, Akif Dogan, Zeynep Yuksel, Sedat Yildirim

World J Urol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data.
Osman Sütcüoğlu, Akif Doğan, Funda Yilmaz, Ahmet Bilgehan Şahin, Taha Koray Şahin

Pancreas· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?
Hatice Odabas, Akif Dogan, Melike Ozcelik, Sedat Yildirim, Ugur Ozkerim

Medicina (Kaunas)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study.
Hasan Çağrı Yıldırım, Emel Mutlu, Elvin Chalabiyev, Miraç Özen, Merve Keskinkılıç

Breast· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer?
Murat Ayhan, Şahin Laçin, Deniz T Özyükseler, Heves Sürmeli, Akif Doğan

J Oncol Pharm Pract· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary testicular lymphoma: Two case reports and review of the literature.
Basri Cakiroglu, Seyit Erkan Eyyupoglu, Akif Nuri Dogan, Umit Noseri, Suleyman Hilmi Aksoy

Arch Ital Urol Androl· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of greenlight photoselective vaporisation of prostate in lower urinary tract symptoms due to benign prostatic hyperplasia in patients using anticoagulants due to cardiovascular comorbidities.
Basri Cakiroglu, Orhun Sinanoglu, Akif Nuri Dogan

Arch Ital Urol Androl· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual cause of hematuria; primary epiploic appendagitis.
Basri Cakiroglu, Orhun Sinanoglu, İlker Abci, Tuncay Tas, Akif Nuri Dogan

Int J Surg Case Rep· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil lymphocyte ratio can be a valuable marker in defining disease activity in patients who have started anti-tumor necrosis factor (TNF) drugs for ankylosing spondylitis.
Belkıs Nihan Coşkun, Mustafa Ferhat Öksüz, Selime Ermurat, Ayşe Nur Tufan, Nurdan Oruçoğlu

Eur J Rheumatol· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A case of recurrent renal aluminum hydroxide stone.
Basri Cakıroglu, Akif Nuri Dogan, Tuncay Tas, Ramazan Gozukucuk, Bekir Sami Uyanik

Case Rep Urol· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis